May 7, 1998
AMERIPATH ENTERS WISCONSIN MARKET

Riviera Beach, Florida - May 7, 1998 - AmeriPath, Inc. (Nasdaq: PATH), a physician practice management company focused on anatomic pathology services, announced today that it has entered into a long-term management agreement with a hospital-based pathology practice, Consultant Physicians in Pathology (CPIP) located in Beaver Dam, Wisconsin.

CPIP is a leading provider of anatomic pathology services in south central Wisconsin that employs five pathologists who provide diagnostic services to six hospitals and one outpatient lab. This arrangement is the Company's first entry into the Wisconsin market.

Jim New, President and Chief Executive Officer of AmeriPath stated, "This agreement illustrates our committed expansion efforts in the Midwest region. By entering the Wisconsin market, this assists us securing regional managed care contracts. We feel that CPIP's pathology services will augment AmeriPath's existing practices in the Midwest."

AmeriPath, Inc. believes it is the nation's leading physician practice management company focused on providing anatomic pathology services to physicians, hospitals, national clinical laboratories and managed care organizations. AmeriPath presently operates 19 physician practices in nine states, employs more than 150 pathologists who provide medical services through outpatient pathology laboratories, hospital inpatient laboratories and outpatient surgery centers.

................................................................................................................

This release contains certain forward-looking statements regarding AmeriPath, including its operations and prospects. Past performance is not necessarily indicative of future results. In addition, AmeriPath's actual results could differ materially from the results anticipated in these forward-looking statements as a result of uncertainties, including risks relating to demand, pricing, government regulation, payments and reimbursements, dependence upon contacts and pathologists, the market for pathology services, competition, and other factors identified in AmeriPath's filings with the Securities and Exchange Commission.